Your browser doesn't support javascript.
loading
Dynamics of measles immunity from birth and following vaccination.
Wang, Wei; O'Driscoll, Megan; Wang, Qianli; Zhao, Sihong; Salje, Henrik; Yu, Hongjie.
Afiliação
  • Wang W; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • O'Driscoll M; Department of Genetics, University of Cambridge, Cambridge, UK.
  • Wang Q; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • Zhao S; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Salje H; Department of Genetics, University of Cambridge, Cambridge, UK. hs743@cam.ac.uk.
  • Yu H; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China. yhj@fudan.edu.cn.
Nat Microbiol ; 9(7): 1676-1685, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38740931
ABSTRACT
Measles remains a major threat to human health despite widespread vaccination. While we know that maternal antibodies can impair vaccine-induced immunity, the relative contributions of pre-existing immunity levels, maternal and infant characteristics on vaccine responses remain unclear, hampering evidence-based vaccination policy development. Here we combine serological data from 1,505 individuals (aged 0-12 years) in a mother-infant cohort and in a child cohort with empirical models to reconstruct antibody trajectories from birth. We show that while highly heterogeneous across a population, measles antibody evolution is strongly predictive from birth at the individual level, including following vaccination. Further, we find that caesarean section births were linked with 2.56 (95% confidence interval 1.06-6.37) increased odds of primary vaccine failure, highlighting the long-term immunological consequences of birth route. Finally, we use our new understanding of antibody evolution to critically assess the population-level consequences of different vaccination schedules, the results of which will allow country-level evaluations of vaccine policy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina contra Sarampo / Vacinação / Sarampo / Anticorpos Antivirais Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacina contra Sarampo / Vacinação / Sarampo / Anticorpos Antivirais Idioma: En Ano de publicação: 2024 Tipo de documento: Article